Oramed Pharmaceuticals Inc.
ORMP· Nasdaq
ORMPOramed Pharmaceuticals Inc.
Filed Jan 12, 2012 · 10-Q · 43 days after period end · 0001178913-12-000118
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Net Income | -$478.52K | -$602.78K |
| EPS Diluted | $0.01 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oramed Pharmaceuticals Inc. · CIK 1176309 · Engraved from SEC EDGAR
ended Nov 30, 2011 · filed Jan 12, 2012 · 43 d after period end
